14th July 2017- Snibe Co., Ltd. receives the FDA clearance on the commercialization of TSH on MaglumiTM 2000 fully-automatic chemiluminescence immunoassay system. (US FDA 510 (k), K NO. : K162698) .It is the 1st company in China who received FDA cleared on CLIA product.

MEDLAB Asia Pacific 2019 is held in Singapore from March 26th to 28th. This is a trade show where several main solutions and products about Medical, Oncology, Healthcare Industry, Cancer, Laboratory, Healthcare System, Clinical Chemistry, Molecular Diagnostics and Laboratory Medicine tend to put on.

From Feb. 4th to 7th, Snibe brings the latest innovation MAGLUMI X8 to Medlab Middle East with booth No. Z5C20 in Dubai, United Arab Emirates, one of the largest and most influential medical exhibitions across the world, attracting more than 22,000 unique visitors, and housing 500 exhibitors dedicated to sharing the most recent technology available in the IVD, and medical laboratory market.